International Stem Cell Corporation (ISCO)

International Stem Cell Revenue

In the year 2023, International Stem Cell had annual revenue of $7.79M, a decrease of -4.78%. Revenue in the quarter ending December 31, 2023 was $1.89M, a -22.26% decrease year-over-year.

• Revenue (ttm): $7.79M
• Revenue Growth: -4.78%
• P/S Ratio: 0.07
• Revenue / Employee: $268,586
• Employees: 29
• Market Cap: 520.29K USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	7.79M	-391.00K	-4.78%
Dec 31, 2022	8.18M	1.00M	13.99%
Dec 31, 2021	7.18M	48.00K	0.67%
Dec 31, 2020	7.13M	-2.34M	-24.75%
Dec 31, 2019	9.47M	-1.62M	-14.58%
Dec 31, 2018	11.09M	3.63M	48.73%
Dec 31, 2017	7.46M	291.00K	4.06%
Dec 31, 2016	7.17M	-386.00K	-5.11%
Dec 31, 2015	7.55M	534.00K	7.61%
Dec 31, 2014	7.02M	870.00K	14.15%
Dec 31, 2013	6.15M	1.58M	34.60%
Dec 31, 2012	4.57M	35.00K	0.77%
Dec 31, 2011	4.53M	2.96M	188.94%
Dec 31, 2010	1.57M	447.32K	39.90%
Dec 31, 2009	1.12M	618.39K	123.00%
Dec 31, 2008	502.77K	464.01K	1,197.00%
Dec 31, 2007	38.76K	35.94K	1,270.72%
Dec 31, 2006	2.83K	-	-
Dec 31, 2005	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.